Szucs, T. D. and Blank, P. R. and Schwenkglenks, M. and Aapro, M.. (2011) Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia. Oncology, 81 (1). pp. 45-49.
![[img]](https://edoc-vmtest.ub.unibas.ch/style/images/fileicons/application_pdf.png)
|
PDF
- Published Version
96Kb |
Official URL: http://edoc.unibas.ch/dok/A6004745
Downloads: Statistics Overview
Abstract
Intravenous (i.v.) iron supplementation significantly improves the response to erythropoiesis-stimulating agent (ESA)-based therapies in patients with cancer- or chemotherapy-induced anemia. The economic implications of adding i.v. iron to ESA treatment are less well investigated. Published randomized controlled trials do not provide sufficient data for a comprehensive cost-effectiveness analysis.
| Faculties and Departments: | 03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs) |
|---|---|
| UniBasel Contributors: | Schwenkglenks, Matthias and Blank, Patricia R. |
| Item Type: | Article, refereed |
| Article Subtype: | Research Article |
| Publisher: | Karger |
| ISSN: | 0030-2414 |
| e-ISSN: | 1423-0232 |
| Note: | Publication type according to Uni Basel Research Database: Journal article |
| Language: | English |
| Identification Number: |
|
| edoc DOI: | |
| Last Modified: | 25 Oct 2017 07:03 |
| Deposited On: | 13 Sep 2013 07:48 |
Repository Staff Only: item control page